Stocks and Investing Stocks and Investing
Mon, August 13, 2012

David Amsellem Maintained (SUPN) at Buy with Increased Target to $15 on, Aug 13th, 2012


Published on 2024-10-25 00:16:45 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Increased Target from $12 to $15 on, Aug 13th, 2012.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources